Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In addition to the results demonstrating the involvement of MECP2 in MRX, this study shows that the frequency of mutations in MECP2 in the mentally retarded population screened for the fragile X syndrome is comparable to the frequency of the CGG expansions in FMR1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP539906.RA4AijR8DutoxwEhg7Lqv4PzTSLTFHRZaFslb92Vzp6Bw130_assertion description "[In addition to the results demonstrating the involvement of MECP2 in MRX, this study shows that the frequency of mutations in MECP2 in the mentally retarded population screened for the fragile X syndrome is comparable to the frequency of the CGG expansions in FMR1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP539906.RA4AijR8DutoxwEhg7Lqv4PzTSLTFHRZaFslb92Vzp6Bw130_provenance.
• assertion description "[In addition to the results demonstrating the involvement of MECP2 in MRX, this study shows that the frequency of mutations in MECP2 in the mentally retarded population screened for the fragile X syndrome is comparable to the frequency of the CGG expansions in FMR1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP552227.RAT8vhaEczFCn0mS7jH2WdeZYh1wq7lX2Lw0FrQIL2pY4130_assertion description "[In addition to the results demonstrating the involvement of MECP2 in MRX, this study shows that the frequency of mutations in MECP2 in the mentally retarded population screened for the fragile X syndrome is comparable to the frequency of the CGG expansions in FMR1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP552227.RAT8vhaEczFCn0mS7jH2WdeZYh1wq7lX2Lw0FrQIL2pY4130_provenance.
• assertion description "[In addition to the results demonstrating the involvement of MECP2 in MRX, this study shows that the frequency of mutations in MECP2 in the mentally retarded population screened for the fragile X syndrome is comparable to the frequency of the CGG expansions in FMR1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition to the results demonstrating the involvement of MECP2 in MRX, this study shows that the frequency of mutations in MECP2 in the mentally retarded population screened for the fragile X syndrome is comparable to the frequency of the CGG expansions in FMR1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP314942.RArL48LoKzhTDNRKyrNBCNNWiJeaRPd1nCs2K2RIEAg9E130_assertion description "[In addition to the results demonstrating the involvement of MECP2 in MRX, this study shows that the frequency of mutations in MECP2 in the mentally retarded population screened for the fragile X syndrome is comparable to the frequency of the CGG expansions in FMR1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP314942.RArL48LoKzhTDNRKyrNBCNNWiJeaRPd1nCs2K2RIEAg9E130_provenance.
• NP314944.RAimYNNnV4y2xB1aVZqdgrN4WjHYwu2Prr35IUgVt3lZU130_assertion description "[In addition to the results demonstrating the involvement of MECP2 in MRX, this study shows that the frequency of mutations in MECP2 in the mentally retarded population screened for the fragile X syndrome is comparable to the frequency of the CGG expansions in FMR1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP314944.RAimYNNnV4y2xB1aVZqdgrN4WjHYwu2Prr35IUgVt3lZU130_provenance.
• NP551879.RALbizOWc8Ko4lNAPlXWopNQ8_F_MhmKSlVY2tkyvXyiQ130_assertion description "[In addition to the results demonstrating the involvement of MECP2 in MRX, this study shows that the frequency of mutations in MECP2 in the mentally retarded population screened for the fragile X syndrome is comparable to the frequency of the CGG expansions in FMR1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP551879.RALbizOWc8Ko4lNAPlXWopNQ8_F_MhmKSlVY2tkyvXyiQ130_provenance.
• NP314939.RAO-WbgNSaFcR5LzhK7bGKE1w5pUAW_oriLZvljqz8FDs130_assertion description "[In addition to the results demonstrating the involvement of MECP2 in MRX, this study shows that the frequency of mutations in MECP2 in the mentally retarded population screened for the fragile X syndrome is comparable to the frequency of the CGG expansions in FMR1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP314939.RAO-WbgNSaFcR5LzhK7bGKE1w5pUAW_oriLZvljqz8FDs130_provenance.
• NP314943.RA5JHVq6W7rANRNu1yHAmo5b5R4124Ywg7llAtpr8_6Rs130_assertion description "[In addition to the results demonstrating the involvement of MECP2 in MRX, this study shows that the frequency of mutations in MECP2 in the mentally retarded population screened for the fragile X syndrome is comparable to the frequency of the CGG expansions in FMR1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP314943.RA5JHVq6W7rANRNu1yHAmo5b5R4124Ywg7llAtpr8_6Rs130_provenance.